Yüklüyor......
Profile of temsirolimus in the treatment of advanced renal cell carcinoma
Temsirolimus is a potent inhibtor of the mammalian target of rapamycin (mTOR). In various clinical trials temsirolimus has shown an overall survival benefit for patients with metastatic renal cell carcinoma (mRCC). Thus it is approved for first-line therapy in high-risk mRCC patients. We discuss the...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2962305/ https://ncbi.nlm.nih.gov/pubmed/21049085 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|